Pulmonary Disposition of TR-700 Following Once-Daily Oral 200 mg

Inclusion Criteria: * Healthy males and females, between 18 and 55 years of age, inclusive * Females must be nonpregnant, nonlactating, and either postmenopausal or surgically sterile or practicing an effective method of birth control * Males must be surgically sterile, abstinent, or practicing an effective method of birth control * BMI between 20 and 34.9 kg/m2, inclusive Exclusion Criteria: * Allergy to lidocaine, midazolam, or other anesthetics/sedatives of similar classes * Physician-diagnosed migraine headaches within 3 years * Previous enrollment in a TR-701 or TR-701 FA trial